Cardiol Therapeutics Inc. Class A Common Shares — Institutional Ownership
Which tracked institutions hold CRDL, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
4
Funds holding
$816078
Total value held
Buying
3 added/new · 1 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Goldman Sachs Group Inc | $448740 | 332400 | +3900 | +1.19% |
| 2 | Morgan Stanley | $338068 | 250421 | -94042 | -27.30% |
| 3 | Royal Bank Of Canada | $29000 | 21648 | — | NEW BUY |
| 4 | Barclays Plc | $270 | 200 | — | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.